Please Wait.....
Report
MEA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-01-01 I 225 Pages I Data Bridge Market Research
Middle East and Africa throat cancer diagnostics market is projected to register a substantial CAGR of 5.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Middle East and Africa Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, the Rest of the Middle East and Africa) Industry Trends and Forecast to 2030
- Rise in healthcare expenditure for cancer diagnosis and treatment
- Novel technological advancements in cancer diagnostics
Market Players:
Some of the key market players in Middle East and Africa throat cancer diagnostics market are listed below:
- F. Hoffmann-La Roche Ltd.
- FUJIFILM Corporation
- Thermo Fisher Scientific Inc.
- Koninklijke Philips N.V.
- Merck KGaA
- BD
- General Electric Company
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Abbott
- QIAGEN
- Siemens Healthcare GmbH
- Quest Diagnostics Incorporated
- Hologic
- PlexBio
TABLE OF CONTENTS
1 INTRODUCTION 46
1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET 46
1.4 LIMITATIONS 48
1.5 MARKETS COVERED 48
2 MARKET SEGMENTATION 51
2.1 MARKETS COVERED 51
2.2 GEOGRAPHICAL SCOPE 52
2.3 YEARS CONSIDERED FOR THE STUDY 53
2.4 CURRENCY AND PRICING 53
2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
2.6 MULTIVARIATE MODELLING 57
2.7 PRODUCT TYPE LIFELINE CURVE 57
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
2.9 DBMR MARKET POSITION GRID 59
2.10 MARKET END USER COVERAGE GRID 60
2.11 VENDOR SHARE ANALYSIS 61
2.12 SECONDARY SOURCES 62
2.13 ASSUMPTIONS 62
3 EXECUTIVE SUMMARY 63
4 PREMIUM INSIGHTS 66
4.1 PESTEL ANALYSIS 67
4.2 PORTER'S FIVE FORCES 68
5 INDUSTRY INSIGHTS 69
6 EPIDEMIOLOGY 70
7 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS 71
7.1 REGULATORY SCENARIO IN THE U.S 71
7.2 REGULATORY SCENARIO IN AUSTRALIA 72
7.3 REGULATORY SCENARIO IN JAPAN 72
7.4 REGULATORY SCENARIO IN CHINA 72
8 MARKET OVERVIEW 74
8.1 DRIVERS 76
8.1.1 GROWING PREVALENCE OF THROAT CANCER 76
8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS 76
8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER 77
8.2 RESTRAINTS 77
8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER 77
8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES. 77
8.3 OPPORTUNITIES 78
8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 78
8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 79
8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 79
8.4 CHALLENGES 80
8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 80
8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 80
9 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 81
9.1 OVERVIEW 82
9.2 INSTRUMENTS 85
9.2.1 PATHOLOGY-BASED INSTRUMENTS 86
9.2.1.1 PCR INSTRUMENTS 86
9.2.1.2 SLIDE STAINING SYSTEMS 86
9.2.1.3 TISSUE PROCESSING SYSTEMS 87
9.2.1.4 CELL PROCESSORS 87
9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 87
9.2.2 IMAGING INSTRUMENTS 87
9.2.2.1 ULTRASOUND SYSTEMS 87
9.2.2.2 CT SYSTEMS 87
9.2.2.3 MRI SYSTEMS 87
9.2.2.4 OTHERS 88
9.2.3 BIOPSY INSTRUMENTS 88
9.2.4 OTHERS 88
9.3 CONSUMABLES & ACCESSORIES 88
9.3.1 KITS 89
9.3.1.1 PCR KITS 89
9.3.1.2 DNA POLYMERASE KITS 89
9.3.1.3 NUCLEIC ACID ISOLATION KITS 89
9.3.1.4 OTHERS 90
9.3.2 REAGENTS 90
9.3.2.1 ASSAYS 90
9.3.2.2 BUFFERS 90
9.3.2.3 PRIMERS 90
9.3.2.4 OTHERS 90
9.3.3 PROBES 90
9.3.4 OTHER CONSUMABLES 90
10 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE 91
10.1 OVERVIEW 92
10.2 IMAGING TEST 95
10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 96
10.2.2 MRI 96
10.2.3 CHEST X-RAY 96
10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 96
10.2.5 OTHERS 96
10.3 BLOOD TEST 96
10.3.1 BLOOD CHEMISTRY TESTS 98
10.3.2 COMPLETE BLOOD COUNT (CBC) 98
10.3.3 OTHERS 98
10.4 BIOPSY 98
10.4.1 ENDOSCOPIC BIOPSY 99
10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY 99
10.4.3 OTHERS 99
10.5 OTHERS 100
11 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 101
11.1 OVERVIEW 102
11.2 PHARYNGEAL CANCER 105
11.2.1 NASOPHARYNGEAL CANCER 106
11.2.2 OROPHARYNGEAL CANCER 106
11.2.3 HYPOPHARYNGEAL CANCER 106
11.3 LARYNGEAL CANCER 107
12 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES 108
12.1 OVERVIEW 109
12.2 STAGE III 112
12.3 STAGE II 112
12.4 STAGE IV 113
12.5 STAGE I 114
12.6 STAGE 0 115
13 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE 116
13.1 OVERVIEW 117
13.2 30-65 120
13.3 65 AND ABOVE 121
13.4 21-29 121
13.5 BELOW 21 122
14 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER 123
14.1 OVERVIEW 124
14.2 HOSPITALS 127
14.3 ASSOCIATED LABS 127
14.4 INDEPENDENT DIAGNOSTIC LABORATORIES 128
14.5 DIAGNOSTIC IMAGING CENTERS 129
14.6 CANCER RESEARCH INSTITUTES 130
14.7 OTHERS 131
15 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 132
15.1 OVERVIEW 133
15.2 DIRECT TENDER 136
15.3 RETAIL SALES 137
16 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, BY REGION 138
16.1 MIDDLE EAST AND AFRICA 139
16.1.1 SAUDI ARABIA 150
16.1.2 U.A.E 155
16.1.3 SOUTH AFRICA 160
16.1.4 EGYPT 165
16.1.5 ISRAEL 170
16.1.6 REST OF MIDDLE EAST AND AFRICA 175
17 MIDDLE EAST & AFRICA THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 176
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 176
18 SWOT ANALYSIS 177
19 COMPANY PROFILE 178
19.1 F. HOFFMANN- LA ROCHE LTD 178
19.1.1 COMPANY SNAPSHOT 178
19.1.2 REVENUE ANALYSIS 178
19.1.3 COMPANY SHARE ANALYSIS 179
19.1.4 PRODUCT PORTFOLIO 179
19.1.5 RECENT DEVELOPMENT 179
19.2 FUJIFILM CORPORATION 180
19.2.1 COMPANY SNAPSHOT 180
19.2.2 REVENUE ANALYSIS 180
19.2.3 COMPANY SHARE ANALYSIS 181
19.2.4 PRODUCT PORTFOLIO 181
19.2.5 RECENT DEVELOPMENT 181
19.3 THERMO FISHER SCIENTIFIC INC. 182
19.3.1 COMPANY SNAPSHOT 182
19.3.2 REVENUE ANALYSIS 182
19.3.3 COMPANY SHARE ANALYSIS 183
19.3.4 PRODUCT PORTFOLIO 183
19.3.5 RECENT DEVELOPMENTS 183
19.4 CANON MEDICAL SYSTEMS CORPORATION 184
19.4.1 COMPANY SNAPSHOT 184
19.4.2 REVENUE ANALYSIS 184
19.4.3 COMPANY SHARE ANALYSIS 185
19.4.4 PRODUCT PORTFOLIO 185
19.4.5 RECENT DEVELOPMENT 185
19.5 KONINKLIJKE PHILIPS N.V. 186
19.5.1 COMPANY SNAPSHOT 186
19.5.2 REVENUE ANALYSIS 186
19.5.3 COMPANY SHARE ANALYSIS 187
19.5.4 PRODUCT PORTFOLIO 187
19.5.5 RECENT DEVELOPMENT 188
19.6 ABBOTT 189
19.6.1 COMPANY SNAPSHOT 189
19.6.2 REVENUE ANALYSIS 189
19.6.3 PRODUCT PORTFOLIO 190
19.6.4 RECENT DEVELOPMENTS 190
19.7 AGILENT TECHNOLOGIES, INC. 191
19.7.1 COMPANY SNAPSHOT 191
19.7.2 REVENUE ANALYSIS 191
19.7.3 PRODUCT PORTFOLIO 192
19.7.4 RECENT DEVELOPMENT 192
19.8 BD 193
19.8.1 COMPANY SNAPSHOT 193
19.8.2 REVENUE ANALYSIS 193
19.8.3 PRODUCT PORTFOLIO 194
19.8.4 RECENT DEVELOPMENTS 194
19.9 BEIJING O&D BIOTECH CO., LTD. 195
19.9.1 COMPANY SNAPSHOT 195
19.9.2 PRODUCT PORTFOLIO 195
19.9.3 RECENT DEVELOPMENT 195
19.10 BIO-RAD LABORATORIES, INC. 196
19.10.1 COMPANY SNAPSHOT 196
19.10.2 REVENUE ANALYSIS 196
19.10.3 PRODUCT PORTFOLIO 197
19.10.4 RECENT DEVELOPMENT 197
19.11 FONAR CORP. 198
19.11.1 COMPANY SNAPSHOT 198
19.11.2 REVENUE ANALYSIS 198
19.11.3 PRODUCT PORTFOLIO 199
19.11.4 RECENT DEVELOPMENT 199
19.12 GE HEALTHCARE 200
19.12.1 COMPANY SNAPSHOT 200
19.12.2 REVENUE ANALYSIS 200
19.12.3 PRODUCT PORTFOLIO 201
19.12.4 RECENT DEVELOPMENT 201
19.13 HOLOGIC INC. 202
19.13.1 COMPANY SNAPSHOT 202
19.13.2 REVENUE ANALYSIS 202
19.13.3 PRODUCT PORTFOLIO 203
19.13.4 RECENT DEVELOPMENT 203
19.14 ILLUMINA, INC. 204
19.14.1 COMPANY SNAPSHOT 204
19.14.2 REVENUE ANALYSIS 204
19.14.3 PRODUCT PORTFOLIO 205
19.14.4 RECENT DEVELOPMENT 205
19.15 MEDONICA CO. LTD 206
19.15.1 COMPANY SNAPSHOT 206
19.15.2 PRODUCT PORTFOLIO 206
19.15.3 RECENT DEVELOPMENT 206
19.16 MERCK KGAA 207
19.16.1 COMPANY SNAPSHOT 207
19.16.2 REVENUE ANALYSIS 207
19.16.3 PRODUCT PORTFOLIO 208
19.16.4 RECENT DEVELOPMENT 208
19.17 MINFOUND MEDICAL SYSTEMS CO., LTD 209
19.17.1 COMPANY SNAPSHOT 209
19.17.2 PRODUCT PORTFOLIO 209
19.17.3 RECENT DEVELOPMENT 209
19.18 MYRIAD GENETICS, INC. 210
19.18.1 COMPANY SNAPSHOT 210
19.18.2 REVENUE ANALYSIS 210
19.18.3 PRODUCT PORTFOLIO 211
19.18.4 RECENT DEVELOPMENT 211
19.19 PLEXBIO 212
19.19.1 COMPANY SNAPSHOT 212
19.19.2 PRODUCT PORTFOLIO 212
19.19.3 RECENT DEVELOPMENT 212
19.20 QIAGEN 213
19.20.1 COMPANY SNAPSHOT 213
19.20.2 REVENUE ANALYSIS 213
19.20.3 PRODUCT PORTFOLIO 214
19.20.4 RECENT DEVELOPMENT 214
19.21 QUEST DIAGNOSTICS INCORPORATED 215
19.21.1 COMPANY SNAPSHOT 215
19.21.2 REVENUE ANALYSIS 215
19.21.3 PRODUCT PORTFOLIO 216
19.21.4 RECENT DEVELOPMENT 216
19.22 SIEMENS HEALTHCARE GMBH 217
19.22.1 COMPANY SNAPSHOT 217
19.22.2 REVENUE ANALYSIS 217
19.22.3 PRODUCT PORTFOLIO 218
19.22.4 RECENT DEVELOPMENT 218
19.23 STERNMED GMBH 219
19.23.1 COMPANY SNAPSHOT 219
19.23.2 PRODUCT PORTFOLIO 219
19.23.3 RECENT DEVELOPMENT 219
19.24 TIME MEDICAL HOLDING. 220
19.24.1 COMPANY SNAPSHOT 220
19.24.2 PRODUCT PORTFOLIO 220
19.24.3 RECENT DEVELOPMENT 220
20 QUESTIONNAIRE 221
21 RELATED REPORTS 225
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security